Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25997905)

Published in Am J Prev Med on May 18, 2015

Authors

Jun Li1, Guixiang Zhao2, Ingrid J Hall3

Author Affiliations

1: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia. Electronic address: ffa2@cdc.gov.
2: Division of Population Health (Zhao), National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia.
3: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia.

Articles citing this

What's new in screening in 2015? Curr Opin Urol (2016) 0.77

Articles cited by this

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 15.83

Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 8.14

Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med (2004) 5.18

Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol (2011) 2.51

Screening for prostate cancer. Cochrane Database Syst Rev (2013) 2.29

Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2013) 2.05

Prevalence of cancer screening in older, racially diverse adults: still screening after all these years. Arch Intern Med (2011) 1.98

Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin (2014) 1.95

Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health (2004) 1.55

Inconsistencies in patient perceptions and observer ratings of shared decision making: the case of colorectal cancer screening. Patient Educ Couns (2010) 1.35

National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med (2013) 1.11

Prostate-specific antigen testing: men's responses to 2012 recommendation against screening. Am J Prev Med (2013) 1.05

Shared decision making in prostate-specific antigen testing with men older than 70 years. J Am Board Fam Med (2013) 0.80